Editorial: Measurable residual disease in hematologic malignancies.

Buccisano, Francesco; Palmieri, Raffaele; Guzman, Monica L; Galimberti, Sara

Buccisano, Francesco; Palmieri, Raffaele; Guzman, Monica L; Galimberti, Sara.

Afiliación

Buccisano F; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Palmieri R; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Guzman ML; Weill Cornell Medicine, Cornell University, White Plains, NY, United States.
Galimberti S; Division of Hematology, University Hospital of Pisa, Pisa, Italy.

Front Oncol ; 13: 1204393, 2023.

Article en En | MEDLINE | ID: mdl-37234991

Palabras clave

MRD - measurable residual disease; chimerism after allo-HSCT; multiparameter flow cytometry; next generation flow cytometry (NGF); next generation sequencing; polymerase chain reaction; surrogate endpoint biomarker

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google